Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
4
Bearish filings
27
Named actors
16
Disclosed $ (bull / bear)
$0 / $2.2M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-20 | Director Astley-Sparke Philip | gifted | — | SEC ↗ |
| 2026-08-17 | Chief Financial Officer Hill Emily Luisa | sold | $132K | SEC ↗ |
| 2026-08-11 | Activist (13D) — reduced stake BAKER BROS. ADVISORS LP | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-10 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-08-10 | Chief Accounting Officer Schwendenman Andrew | sold | $99K | SEC ↗ |
6 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-10 | Chief Medical Officer Xynos Konstantinos | sold | $148K | SEC ↗ |
| 2026-08-10 | Chief Financial Officer Hill Emily Luisa | sold | $148K | SEC ↗ |
| 2026-08-10 | Chief Executive Officer Patel Sushil | sold | $510K | SEC ↗ |
| 2026-08-07 | 5%+ holder (13G) STATE STREET CORP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-01 | Chief Commercial Officer Sarchi Christopher | sold | $111K | SEC ↗ |
| 2026-05-21 | 5%+ holder (13G) Ridgeback Capital Investments L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-18 | Chief Financial Officer Hill Emily Luisa | sold | $40K | SEC ↗ |
| 2026-05-18 | Chief Executive Officer Patel Sushil | sold | $190K | SEC ↗ |
| 2026-05-18 | Director Astley-Sparke Philip | sold | $90K | SEC ↗ |
| 2026-05-18 | Chief Commercial Officer Sarchi Christopher | sold | $44K | SEC ↗ |
| 2026-05-18 | Chief Accounting Officer Schwendenman Andrew | sold | $40K | SEC ↗ |
| 2026-05-18 | Chief Medical Officer Xynos Konstantinos | sold | $71K | SEC ↗ |
| 2026-05-12 | 5%+ holder (13G) SUVRETTA CAPITAL MANAGEMENT, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-02 | Chief Commercial Officer Sarchi Christopher | sold | $52K | SEC ↗ |
| 2026-04-02 | Officer (via J.P. Morgan Securities LLC) Christopher Sarchi | filed notice to sell | $142K | SEC ↗ |
| 2026-02-18 | Director Astley-Sparke Philip | gifted | — | SEC ↗ |
| 2026-02-03 | Chief Commercial Officer Christopher Sarchi | adopted a selling plan | — | SEC ↗ |
| 2026-02-03 | Chief Accounting Officer Andrew Schwendenman | adopted a selling plan | — | SEC ↗ |
| 2025-12-09 | Director Dhingra Kapil | sold | $33K | SEC ↗ |
| 2025-12-09 | Director (via J.P. Morgan Securities LLC) Kapil Dhingra | filed notice to sell | $33K | SEC ↗ |